CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-15 | Reali Kenneth Michael Chief Executive Officer | Sale | −9,811 | $1.39 | $14K | 30,085 |
| 2023-03-14 | Reali Kenneth Michael Chief Executive Officer | Exercise or conversion | +28,721 | 39,896 | ||
| 2023-03-14 | Reali Kenneth Michael Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −28,721 | 86,161 | ||
| 2022-03-14 | Reali Kenneth Michael Fmr. CEO and Director | Grant or award · Stock Option (Right to Buy) | +466,054 | 466,054 | ||
| 2022-03-14 | Reali Kenneth Michael Chief Executive Officer | Grant or award · Restricted Stock Units | +114,882 | 114,882 | ||
| 2021-09-09 | Reali Kenneth Michael CHIEF EXECUTIVE OFFICER | Purchase | +1,800 | $14.81 | $27K | 11,175 |
| 2021-04-01 | Reali Kenneth Michael Chief Executive Officer | Grant or award · Stock Options | +30,000 | 30,000 | ||
| 2021-02-11 | Reali Kenneth Michael Chief Executive Officer | Purchase | +9,375 | $13.00 | $122K | 9,375 |
Page 1 of 1 · 8 trades